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Objective:Itisimportantthatduringpreoperativeskinpreparationsurgicalsitemarkings
are not erased. The effects of 2 common types of skin preparation solutions on surgical
site markings were compared. Methods: Fasciocutaneous skin flaps were harvested and
20randomcombinationsof3letterswerewrittenontheskinflapswithablackpermanent
marker. Ten of the 3-letter combinations received Chloraprep (chlorhexidine gluconate,
2% w/v, plus isopropyl alcohol, 70% v/v) and the other 10 received Duraprep (iodine
povacrylex [0.7% available iodine] and isopropyl alcohol [74% w/w]), both according
to the manufacturer’s guidelines. The skin flaps were photographed digitally before
andafterapplicationofthesolutions.Thefinalpictureswereassessedsubjectivelyby10
surgeonsandthenobjectivelytodeterminethechangeinvisibilityofthemarkingoneach
specimen. Results: Of the 300 letters in each group, the number of correctly identified
letters was 254 (84.7%) in the Chloraprep group and 284 (94.7%) in the Duraprep
group. On the basis of the visibility of skin markings, Chloraprep was 21.8 times more
likely (95% credible interval, 7.3–86.7) to erase the site markings than was Duraprep.
Conclusions: Skin preparation with Chloraprep erased more surgical site markings than
did Duraprep.
Marking the surgical site is essential for the planning of any surgical procedure and
for the prevention of wrong-site surgery. Recently, the American Academy of Orthopaedic
Surgeons1 issued an advisory statement and developed the “sign your site” awareness cam-
paign to reduce the incidence of wrong-site surgery. In 2003, the Joint Commission on
Accreditation of Healthcare Organizations2 developed guidelines that require preoperative
verification of the surgery site and patient, marking of the surgical site on the patient, and a
“time-out” in the operating room to verify the patient data. In addition, several specialties
use skin marking to design surgical incisions preoperatively. Mammoplasty, for example,
requires the markings to be made with the patient in the supine position and anesthetized.
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The Centers for Disease Control and Prevention3 has recommended the use of “an
appropriate antiseptic agent for skin preparation” to prevent surgical site infections. The
mostcommonsourceofpostoperativeinfectionisthepatient’sownskinflora.4 Surgicalskin
preparation solutions usually contain iodine or chlorhexidine and they can be aqueous or
alcoholic. Two common products used for skin preparation are Chloraprep (chlorhexidine
gluconate, 2% w/v and isopropyl alcohol, 70% v/v; Enturia Inc, Leawood, Kansas) and
Duraprep(Iodophor,0.7%availableiodineandisopropylalcohol,74%w/w;3MHealthcare,
SaintPaul,Minnesota).Chlorhexidinegluconate,acomponentofChloraprep,isachemical
antiseptic that is bactericidal and fungicidal with little effect on spores, mycobacteria, and
viruses. The mechanism of action is thought to be membrane disruption.5 Iodophor (0.7%
availableiodine),acomponentofDuraprep,isacomplexofiodineandasolubilizingagentor
carrier, which acts as a reservoir of the active, “free” iodine. Iodine is rapidly bactericidal,
fungicidal, tuberculocidal, virucidal, and sporicidal.5 It is noteworthy that both surgical
preparations contain 70% or more isopropyl alcohol, which exhibits rapid, broad-spectrum
antimicrobial activity against vegetative bacteria (including mycobacteria), viruses, and
fungi but not spores. Little is known about the specific mode of action of alcohols but it
is generally thought that they cause membrane damage and rapid denaturation of proteins,
with subsequent interference with metabolism and cell lysis.5 Evidence on which to base
a choice between these products is sparse and sometimes conflicting. In terms of reducing
infection, chlorhexidine gluconate has been shown to be superior to povidone iodine for
skin preparation for vascular catheter insertion.6 Chlorhexidine gluconate also has been
shown to be better than povidone iodine in reducing bacterial skin counts for procedures
such as vaginal hysterectomy7 and foot and ankle surgery.8,9 Duraprep has been shown
to be superior in allowing adhesion of drapes to skin.10 Despite the lack of evidence of
superiority of one solution versus another, patient safety specialists are recommending that
chlorhexidene solutions be used for surgical skin preparation. In our and other hospital
systems, this recommendation is becoming a mandatory switch to one particular product, a
chlorhexidene-based skin preparation solution for which a 30-second scrub application is
recommended.
We have observed that the skin preparation often smudges the marks, rendering them
illegible, or erases them completely. In our study, we compared the effects of 2 widely
available surgical skin preparation solutions, Chloraprep and Duraprep, on skin markings.
METHODS
Specimens and procedures
Three skin flaps were harvested from the thighs of Caucasian male cadavers obtained from
the State Anatomy Board. Before marking, the flaps were thawed to room temperature
(20˚C), as confirmed with a thermocouple (K-type, Omega Engineering Inc, Stamford,
Connecticut) inserted into the epidermis.
To replicate initials typically seen in the operating room for site marking, 20 random
3-letter combinations were generated with MS Excel (Microsoft Office 2003, Microsoft
Corporation, Seattle, Washington). A black permanent marker routinely used in the operat-
ing room (Super Sharpie Series 33000, Sanford Corporation, Oak Brook, Illinois) was used
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to mark the skin. The initials were drawn as capital letters (4- to 5-cm tall) and underlined.
The writing was allowed to dry for at least 15 minutes before the solution was applied.
Pre-preparation pictures then were obtained with a digital still camera (Digital Rebel XTi,
Canon USA, Lake Success, New York) with a 100-mm macro lens (EF 100mm f/2.8 USM
MacroLens,CanonUSA,LakeSuccess,NewYork)andringflash(MR-14EXTTL,Canon
USA, Lake Success, New York). The camera captures at 10.1 megapixels and the shutter
speed was set at 1 per 60 seconds with an F-stop value of 4.0. In all cases, we used a tripod
to position the camera at a fixed distance from the skin.
HalfoftheinitialswerepreppedwithChloraprepandtheotherhalfwithDuraprep.The
solutions were applied according to the manufacturers’ guidelines. For the Chloraprep, the
method involved repeated forward and backward strokes for 30 seconds. For the Duraprep,
themethodinvolvedpaintingasinglelayerofthesolutionontotheskinwithoutscrubbingit.
Allspecimenswereallowedtodryfullyforatleast3minutes.Postpreparationpictureswere
taken, numbered randomly, and made into a digital presentation (PowerPoint, Microsoft
Office 2003, Microsoft Corporation, Seattle, Washington). The presentation was shown
separately to 10 surgeons. Each was asked to write down the letters in each photograph and
to indicate whether the initials could be seen well enough to perform a surgical time-out.
All raw digital pictures were converted into a gray scale with 256 levels, using Adobe
PhotoshopCS2(Adobe,SanJose,California),with0beingthedarkestand255beingwhite.
The histogram tool was used to determine the mean gray level of the line drawn under each
set of initials (for quantitative assessment) and of the strip of adjacent skin. The difference
between the 2 mean gray levels provided a measure of the contrast between the writing
and the skin in any given image. This contrast was determined for each specimen in the
preapplication and postapplication photographs.
The effect of skin preparation on the odds of recognizing skin markings was analyzed
usingtheBayesmethodwithanormal(0,10E6)priordistribution(WinBUGS,Version1.4,
Imperial College, London, UK).
RESULTS
Subjective assessment
The 10 surgeons correctly identified 254 of 300 individual letters in the Chloraprep group
and 284 of 300 letters in the Duraprep group (84.7% vs 94.7%, respectively). Only 58 of
100 sets of initials (58%) in the Chloraprep group were recognized well enough (Fig 1)
by the surgeon to perform a surgical time-out, compared with 92 of 100 sets (92%) in the
Duraprep group. The posterior distribution of odds ratios indicated that Chloraprep was
21.8 times more likely (95% credible interval, 7.3–86.7) to erase the initials than Duraprep.
Objective assessment
The mean change in gray scale contrast for the Chloraprep group was 39.3 units (95% cred-
ible interval, 30.8–48.3), whereas that for the Duraprep group was 17.7 units (95% credible
interval,9.4–26.1).ThischangeincontrastindicatesthatthemarksintheChloraprepgroup
were erased more than the marks in the Duraprep group.
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Figure 1a–1d. Specimens before and after skin preparation with a chlorhexidine-based solution (a
and b, respectively) or an iodine-based solution (c and d, respectively).
DISCUSSION
In our study, we showed that skin preparation with Chloraprep was more likely to erase
site markings than skin preparation with Duraprep. With increasing awareness about the
preventionofwrong-sitesurgery,visibilityofthesitemarkingisessential.Indeed,oneofthe
recommendationsoftheJointCommissiononAccreditationofHealthcareOrganizations2 is
that“theintendedsitemustbemarkedsuchthatthemarkwillbevisibleafterthepatienthas
beenpreppedanddraped.”Site-markingerasurecreatesamajorproblemforthesurgeonand
operatingpersonnel.Duringplasticsurgery,thesemarkings,essentialforthereconstructive
plan, are made with the patient awake and cannot be recreated with the patient anesthetized.
Theerasureofsiteidentificationmarkingsalsocreatesaprobleminperforminganaccurate
surgical time-out. One solution used in some hospitals is to do the time-out before skin
preparation. In our institution, hospital policy indicates that surgical time-out should be
done after skin preparation and draping and just before skin incision. Interestingly, the
Universal Protocol of the Joint Commission on Accreditation of Healthcare Organizations2
provides no guidance on this matter, other than mentioning that any difference of opinion
between members of the surgical team needs to be resolved before the procedure is started.
The American College of Surgeons11 suggests that the surgical site listed on the consent
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form should be confirmed with the patient or the patient’s designated representative. The
use of a surrogate decision maker creates many practical questions and room for error.
Clearly, the solution is to prevent site-marking erasure. Erasure creates a culture within the
operating room setting that denigrates the importance of the surgical time-out in starting
surgery, which represents a retrograde step in the knowledge-attitudes-behavior model for
harm prevention.12
Chloraprep and Duraprep are effective and are used widely throughout the United
States. Each has its advocates, based partly on studies6–9 showing the efficacy of chlorhex-
idine gluconate and povidone iodine. A study in foot and ankle surgery9 showed that a
chlorhexidine-based solution was superior to the iodine-based solution according to quan-
titative culture specimens from various parts of the foot. In vitro experiments have shown
povidone iodine to be superior to chlorhexidine gluconate in terms of killing methicillin-
resistant Staphylococcus aureus13 and reducing the incidence of antimicrobial resistance.14
Although it is possible that removal of marks is a result of a reaction between the
chlorhexidinegluconateandiodophoronthesyntheticpigmentpresentintheblackmarker,
it seems probable that the difference seen is the result of dissimilar application of the
preparations onto the skin. According to the manufacturer’s guidelines, Chloraprep should
be applied by repeated forward and backward strokes for 30 seconds. For Duraprep, the
manufacturer recommends painting a single layer of the solution onto the skin without
scrubbing it. The scrubbing action may be responsible for the greater degree of marking
removal in the chlorhexidine group. Because both preparations contain approximately 70%
isopropylalcohol,thatchemicalsolventisunlikelytoplayanimportantroleinthedifference
seen.
Our study has several limitations. It is possible that dermoepidermal separation seen
in postmortem tissue secondary to rubbing the skin may confound our results. It was not
possible to standardize the amount of ink used to mark each site. Nevertheless, the applica-
tion of ink letters was consistent between specimens assigned to both preparation groups.
We used a standard marking pen for this study but the particular marker we used could be
more susceptible to the effects of Chloraprep than other surgical markers. In the future, the
effects of skin preparation on other types of pen markings are needed to determine whether
a better skin marker exists.
Insummary,skinpreparationwithChlorapreperasedmoresurgical-sitemarkingsthan
did Duraprep. Clinical trials comparing the erasure of skin markings with these 2 solutions
are needed to validate our findings.
REFERENCES
1. American Academy of Orthopaedic Surgeons. Advisory statement on wrong site surgery. Available at:
http://www.aaos.org/about/papers/advistmt/1015.asp. Accessed June 5, 2007.
2. Joint Commission on Accreditation for Healthcare Organizations. National Patient Safety Goals, 2003.
Perspectives on patient safety. July, 2002. Available at: http://www.jointcommission.org/PatientSafety/
NationalPatientSafetyGoals/03 npsgs.htm. Accessed June 5, 2007.
3. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for prevention of surgical site
infection, 1999. Hospital infection control practices advisory committee. Infect Control Hosp Epidemiol.
1999;20:250–78.
368MEARS ET AL
4. Altemeier WA, Culbertson WR, Hummel RP. Surgical considerations of endogenous infections–sources,
types, and methods of control. Surg Clin North Am. 1968;48:227–40.
5. McDonnell G, Russell AD. Antiseptics and disinfectants: activity, action, and resistance. Clin Microbiol
Rev. 1999;12:147–79.
6. Chaiyakunapruk N, Veenstra DL, Lipsky BA, Saint S. Chlorhexidine compared with povidone-iodine so-
lution for vascular catheter-site care: a meta-analysis. Ann Intern Med. 2002;136:792–801.
7. CulliganPJ,KubikK,MurphyM,BlackwellL,SnyderJ.Arandomizedtrialthatcomparedpovidoneiodine
and chlorhexidine as antiseptics for vaginal hysterectomy. Am J Obstet Gynecol. 2005;192:422–5.
8. Bibbo C, Patel DV , Gehrmann RM, Lin SS. Chlorhexidine provides superior skin decontamination in foot
and ankle surgery: a prospective randomized study. Clin Orthop Relat Res. 2005;438:204–8.
9. Ostrander RV , Botte MJ, Brage ME. Efficacy of surgical preparation solutions in foot and ankle surgery. J
Bone Joint Surg Am. 2005;87:980–5.
10. Jacobson C, Osmon DR, Hanssen A, et al. Prevention of wound contamination using Duraprep solution
plus Ioban 2 drapes. Clin Orthop Relat Res. 2005;439:32–7.
11. American College of Surgeons Committee on Processes of Surgical Care and the Member Services Liaison
Committee. Statement on ensuring correct patient, correct site, and correct procedure surgery. Bull Am Coll
Surg. 2002;87:26.
12. Makary MA, Mukherjee A, Sexton JB, et al. Operating room briefings and wrong-site surgery. JA mColl
Surg. 2007;204:236–43.
13. McLureAR,GordonJ.In-vitroevaluationofpovidone-iodineandchlorhexidineagainstmethicillin-resistant
Staphylococcus aureus. J Hosp Infect. 1992;21:291–9.
14. Kunisada T, Yamada K, Oda S, Hara O. Investigation on the efficacy of povidone-iodine against antiseptic-
resistant species. Dermatology. 1997;195:14–8.
369